nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Insomnia—Fluorouracil—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Somnolence—Gemcitabine—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Migraine—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Fatigue—Irinotecan—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Milnacipran—Paraesthesia—Fluorouracil—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Milnacipran—Pruritus—Sunitinib—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Milnacipran—Breast disorder—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Milnacipran—Constipation—Irinotecan—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Dyspnoea—Fluorouracil—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Mental disorder—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Somnolence—Fluorouracil—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Malnutrition—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Milnacipran—Decreased appetite—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Milnacipran—Dyspepsia—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Nausea—Tamoxifen—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Fatigue—Gemcitabine—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Constipation—Gemcitabine—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Nausea—Erlotinib—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Decreased appetite—Fluorouracil—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Diarrhoea—Sunitinib—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Dysgeusia—Docetaxel—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Abdominal distension—Epirubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Milnacipran—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Milnacipran—Dry skin—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Dizziness—Sunitinib—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Angina pectoris—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Milnacipran—Breast disorder—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Abdominal pain—Irinotecan—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Body temperature increased—Irinotecan—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Vomiting—Sunitinib—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Body temperature increased—Gemcitabine—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Neutropenia—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Dysuria—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Rash—Sunitinib—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Dermatitis—Sunitinib—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Abdominal distension—Doxorubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Urticaria—Fluorouracil—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Headache—Sunitinib—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Syncope—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Leukopenia—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Pollakiuria—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Body temperature increased—Fluorouracil—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Palpitations—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Loss of consciousness—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Weight decreased—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Angina pectoris—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Hypersensitivity—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Convulsion—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Hypertension—Docetaxel—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Chest pain—Docetaxel—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Nausea—Sunitinib—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Asthenia—Irinotecan—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Urinary tract infection—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Neutropenia—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Dysuria—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Hypersensitivity—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Dry mouth—Docetaxel—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Pollakiuria—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Asthenia—Gemcitabine—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Haematuria—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Milnacipran—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Pruritus—Gemcitabine—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Infection—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Milnacipran—Diarrhoea—Irinotecan—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Shock—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Nervous system disorder—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Pruritus—Fluorouracil—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Tachycardia—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Skin disorder—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Diarrhoea—Gemcitabine—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Dizziness—Irinotecan—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Anorexia—Docetaxel—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Hepatitis—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Milnacipran—Diarrhoea—Fluorouracil—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Milnacipran—Urinary tract disorder—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Oedema peripheral—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Hypotension—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Connective tissue disorder—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Milnacipran—Urethral disorder—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Vomiting—Irinotecan—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Dizziness—Fluorouracil—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Rash—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Dermatitis—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Headache—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Insomnia—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Paraesthesia—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Erythema multiforme—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Vomiting—Gemcitabine—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Dyspnoea—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Somnolence—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Rash—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Dermatitis—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Eye disorder—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Headache—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Flushing—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Vomiting—Fluorouracil—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Dyspepsia—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Rash—Fluorouracil—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Dermatitis—Fluorouracil—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Milnacipran—Decreased appetite—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Headache—Fluorouracil—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Milnacipran—Fatigue—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Nausea—Irinotecan—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Constipation—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Chills—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Milnacipran—Nausea—Gemcitabine—pancreatic cancer	0.000984	0.000984	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—pancreatic cancer	0.000978	0.000978	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000977	0.000977	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—pancreatic cancer	0.000972	0.000972	CcSEcCtD
Milnacipran—Nausea—Fluorouracil—pancreatic cancer	0.000968	0.000968	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Milnacipran—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Milnacipran—Tension—Epirubicin—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000931	0.000931	CcSEcCtD
Milnacipran—Abdominal pain—Docetaxel—pancreatic cancer	0.00093	0.00093	CcSEcCtD
Milnacipran—Body temperature increased—Docetaxel—pancreatic cancer	0.00093	0.00093	CcSEcCtD
Milnacipran—Chills—Doxorubicin—pancreatic cancer	0.000927	0.000927	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—pancreatic cancer	0.000905	0.000905	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—pancreatic cancer	0.000899	0.000899	CcSEcCtD
Milnacipran—Agitation—Epirubicin—pancreatic cancer	0.000893	0.000893	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Milnacipran—Tension—Doxorubicin—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Milnacipran—Syncope—Epirubicin—pancreatic cancer	0.000872	0.000872	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—pancreatic cancer	0.00087	0.00087	CcSEcCtD
Milnacipran—Hypersensitivity—Docetaxel—pancreatic cancer	0.000866	0.000866	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—pancreatic cancer	0.000859	0.000859	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—pancreatic cancer	0.000854	0.000854	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Milnacipran—Asthenia—Docetaxel—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—pancreatic cancer	0.000839	0.000839	CcSEcCtD
Milnacipran—Pruritus—Docetaxel—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—pancreatic cancer	0.000827	0.000827	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—pancreatic cancer	0.000825	0.000825	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—pancreatic cancer	0.000809	0.000809	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—pancreatic cancer	0.000806	0.000806	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Milnacipran—Diarrhoea—Docetaxel—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—pancreatic cancer	0.000795	0.000795	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Milnacipran—Infection—Epirubicin—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Milnacipran—Shock—Epirubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—pancreatic cancer	0.000779	0.000779	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—pancreatic cancer	0.000778	0.000778	CcSEcCtD
Milnacipran—Dizziness—Docetaxel—pancreatic cancer	0.000778	0.000778	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000777	0.000777	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—pancreatic cancer	0.000776	0.000776	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—pancreatic cancer	0.000771	0.000771	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—pancreatic cancer	0.000749	0.000749	CcSEcCtD
Milnacipran—Vomiting—Docetaxel—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Milnacipran—Rash—Docetaxel—pancreatic cancer	0.000742	0.000742	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Milnacipran—Dermatitis—Docetaxel—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Milnacipran—Headache—Docetaxel—pancreatic cancer	0.000737	0.000737	CcSEcCtD
Milnacipran—Infection—Doxorubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Milnacipran—Shock—Doxorubicin—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00072	0.00072	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—pancreatic cancer	0.000707	0.000707	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Milnacipran—Nausea—Docetaxel—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—pancreatic cancer	0.000698	0.000698	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—pancreatic cancer	0.00069	0.00069	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Milnacipran—Constipation—Epirubicin—pancreatic cancer	0.000678	0.000678	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—pancreatic cancer	0.000654	0.000654	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—pancreatic cancer	0.000653	0.000653	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—pancreatic cancer	0.000646	0.000646	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—pancreatic cancer	0.000628	0.000628	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.0006	0.0006	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—pancreatic cancer	0.000584	0.000584	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—pancreatic cancer	0.000583	0.000583	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—pancreatic cancer	0.000569	0.000569	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—pancreatic cancer	0.000561	0.000561	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—pancreatic cancer	0.000527	0.000527	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—pancreatic cancer	0.000525	0.000525	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—pancreatic cancer	0.000504	0.000504	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—pancreatic cancer	0.000502	0.000502	CcSEcCtD
Milnacipran—Rash—Epirubicin—pancreatic cancer	0.0005	0.0005	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—pancreatic cancer	0.0005	0.0005	CcSEcCtD
Milnacipran—Headache—Epirubicin—pancreatic cancer	0.000497	0.000497	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—pancreatic cancer	0.000485	0.000485	CcSEcCtD
Milnacipran—Nausea—Epirubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—pancreatic cancer	0.000467	0.000467	CcSEcCtD
Milnacipran—Rash—Doxorubicin—pancreatic cancer	0.000463	0.000463	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Milnacipran—Headache—Doxorubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—pancreatic cancer	0.000436	0.000436	CcSEcCtD
